欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
PT/H/0433/001
药品名称
Buprenorfina Aurovitas
活性成分
buprenorphine hydrochloride 2.0 mg
剂型
Sublingual tablet
上市许可持有人
Generis Farmacêutica, S.A.
参考成员国 - 产品名称
Portugal (PT)
互认成员国 - 产品名称
Germany (DE)
Buprenorphin-Actavis 2 mg Sublingualtabletten
许可日期
2011/07/27
最近更新日期
2023/10/26
药物ATC编码
N07BC01 buprenorphine
申请类型
TypeLevel1:
Abridged
TypeLevel2:
Initial Application
TypeLevel3:
Generic Art 10.1 and 10.2 Dir 2001/83/EC
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
Final PL
|
Buprenorphine_PIL_clean
Date of last change:2022/08/12
Final SPC
|
Buprenorphine_SmPC_common_clean
Date of last change:2022/06/02
Final Product Information
|
PI buprenorphine PT_H_433-V003-CL-Day30-resp-04092012
Date of last change:2012/09/08
Final Labelling
|
PI buprenorphine PT_H_433.doc;447-448_01-03_DC - Day 200 proposal CL - 170711
Date of last change:2012/02/07
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase